Metadata Sub-indicator 3.b.1.4. Proporción de la población vacunada contra sarampión
Goal 3. Ensure healthy lives and promote well-being for all at all ages
Target 3.b. Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines forall.
Indicator 3.b.1. Proportion of the target population covered by all vaccines included in their national programme
Sub-indicator 3.b.1.4. Proportion of vaccinated population against measles
- Global
Percentage of boys and girls, of a certain cohort, vaccinated with at least two doses of measles vaccine after 12 months of age
\[ PV_{sarampion}^{cohorte}=\frac{ V_{sarampion}^{cohorte}}{P^{cohorte}} \cdot 100 \]Where: \( V_{sarampion}^{cohorte}\)is the number of people in established cohorts who have received at least two doses of measles vaccine after 12 months of age and \( P^{cohorte}\)is the number of people born in the established years of that cohort.
Percentage
Annual
CCAA
Tier I
No
Estadística de Vacunaciones Sistemáticas (ISO code: 54022)
15/12/2021
WHO, UNICEF